Literature DB >> 15126542

Pituitary magnetic resonance imaging in 15 patients with Prop1 gene mutations: pituitary enlargement may originate from the intermediate lobe.

Antonis Voutetakis1, Maria Argyropoulou, Amalia Sertedaki, Sarantis Livadas, Paraskevi Xekouki, Maria Maniati-Christidi, Ioannis Bossis, Nicolas Thalassinos, Nicholas Patronas, Catherine Dacou-Voutetakis.   

Abstract

Pituitary morphology in patients with Prop1 gene mutations varies. Most patients demonstrate a normal or small pituitary gland. Occasionally, pituitary enlargement of undetermined origin has also been detected. In the present study we use long-term magnetic resonance imaging findings to characterize the morphological abnormalities of the pituitary gland in 15 patients (aged 2.5-45 yr) with combined pituitary hormone deficiency caused by Prop1 gene mutations (GA296del/GA296del in seven, GA296del/A150del in two, A150del/A150del in five, and GA296del/R73H in one patient) and attempt to uncover the origin and nature of the pituitary enlargement. Small pituitary gland was detected in seven patients (25.2 +/- 14.4 yr of age), normal pituitary size in three patients (10.2 +/- 5.8 yr of age), and pituitary enlargement in five patients (6.5 +/- 2.7 yr of age). The pituitary enlargement consisted of a nonenhancing mass lesion interposed between the normally enhancing anterior lobe and the neurohypophysis. The pituitary stalk was displaced anteriorly, whereas the neurohypophysis was orthotopic, displaying a normal signal. Spontaneous regression of the mass lesion with normalization of the pituitary stalk position was observed in three patients. Our data indicate that although a small pituitary gland is usually observed in older subjects, a significant number of young patients with Prop1 gene mutations demonstrate pituitary enlargement with subsequent regression. The distinct magnetic resonance imaging characteristics of the pituitary enlargement in our patients in conjunction with pertinent data from Prop1-deficient mice suggest that the mass causing the pituitary enlargement most likely originates from the intermediate lobe.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15126542     DOI: 10.1210/jc.2003-031765

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

1.  Untreated hypopituitarism due to absence of the pituitary stalk with normal adult height: report of two cases.

Authors:  Leda Papastathopoulou; Marinella Tzanela; Vania Vlassopoulou; Dimitra Vassiliadi; Nikolaos Thalassinos
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

2.  Pituitary size fluctuation in long-term MR studies of PROP1 deficient patients: A persistent pathophysiological mechanism?

Authors:  A Voutetakis; A Sertedaki; S Livadas; P Xekouki; I Bossis; C Dacou-Voutetakis; M I Argyropoulou
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

3.  Case seminar: a young female with acute hyponatremia and a sellar mass.

Authors:  Sandra Pekic; Mirjana Doknic; Dragana Miljic; Alexandru Saveanu; Rachel Reynaud; Anne Barlier; Thierry Brue; Vera Popovic
Journal:  Endocrine       Date:  2011-08-24       Impact factor: 3.633

4.  CTNNB1 gene mutations, pituitary transcription factors, and MicroRNA expression involvement in the pathogenesis of adamantinomatous craniopharyngiomas.

Authors:  Marina Lanciotti Campanini; Leandro Machado Colli; Beatriz Maria Carvalho Paixao; Tatiana Pereira Freitas Cabral; Fernando Colbari Amaral; Helio Rubens Machado; Luciano Serafin Neder; Fabiano Saggioro; Ayrton Custodio Moreira; Sonir Roberto Rauber Antonini; Margaret de Castro
Journal:  Horm Cancer       Date:  2010-08       Impact factor: 3.869

Review 5.  MRI of the hypothalamic-pituitary axis in children.

Authors:  Maria I Argyropoulou; Dimitrios Nikiforos Kiortsis
Journal:  Pediatr Radiol       Date:  2005-06-01

6.  Waxing and waning of a pituitary mass in a young woman with combined pituitary hormone deficiency (CPHD) due to a PROP-1 mutation.

Authors:  Sergio Oliva Nascif; Teresa Cristina Vieira; João Carlos Ramos-Dias; Ana-Maria Judith Lengyel; Julio Abucham
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

Review 7.  Advances in differential diagnosis and management of growth hormone deficiency in children.

Authors:  Camille Hage; Hoong-Wei Gan; Anastasia Ibba; Giuseppa Patti; Mehul Dattani; Sandro Loche; Mohamad Maghnie; Roberto Salvatori
Journal:  Nat Rev Endocrinol       Date:  2021-08-20       Impact factor: 43.330

8.  Combined pituitary hormone deficiency and PROP-1 mutation in two siblings: a distinct MR imaging pattern of pituitary enlargement.

Authors:  L L F do Amaral; R M Ferreira; N P F D Ferreira; R A Mendonça; V H R Marussi; J L da Cunha; B R Maçaranduba; J D Medeiros
Journal:  AJNR Am J Neuroradiol       Date:  2007-08       Impact factor: 3.825

Review 9.  Combined pituitary hormone deficiency: current and future status.

Authors:  F Castinetti; R Reynaud; M-H Quentien; N Jullien; E Marquant; C Rochette; J-P Herman; A Saveanu; A Barlier; A Enjalbert; T Brue
Journal:  J Endocrinol Invest       Date:  2014-09-09       Impact factor: 4.256

Review 10.  Genetic regulation of pituitary gland development in human and mouse.

Authors:  Daniel Kelberman; Karine Rizzoti; Robin Lovell-Badge; Iain C A F Robinson; Mehul T Dattani
Journal:  Endocr Rev       Date:  2009-10-16       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.